利用似然估计处理区域间方差异质性的多区域临床试验设计与评价
多区域临床试验(MRCT)常假设各区域变异度相同,但区域间 ethnicity 或医疗实践差异可导致方差异质性。本文提出一种基于似然估计的统计方法,在设计与评价 MRCT 时考虑区域间方差异质性,评估总样本量需求并确定区域特异性样本量以建立特定区域与整体组治疗效应的一致性,并用数值示例演示。
要点
- MRCT 设计需考虑区域间主要终点变异度的异质性。
- 所提方法可评估总样本量并确定区域特异性样本量。
- 方法用于建立特定区域与整体组治疗效应的一致性。
核心结论
- 提出一种考虑区域间方差异质性的 MRCT 设计与评价统计方法。
研究设计与样本
- 统计方法学研究,提出基于似然估计的方法并用数值示例演示。
主要发现
- 评估了总样本量需求并解决区域特异性样本量确定以建立特定区域与整体组治疗效应一致性。
临床怎么用
- 在 MRCT 设计与评价中可采用该方法处理区域间方差异质性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Globalized drug development studies, such as multiregional clinical trials (MRCTs), have attracted much attention due to their ability to expedite drug development and shorten the time lag of drug release. While observing the overall effect of a new drug, the region-specific effects to support drug registration in constituent regions can also be evaluated. Several challenges arise in conducting MRCTs, such as the heterogeneity in the variability of the primary endpoint across regions. However, most of the existing statistical methods assume a common variability, which may not be valid in practice due to differences across regions (eg, diversities in ethnicity or disparities in medical culture/practice). We present a statistical method for the design and evaluation of MRCTs to consider the heterogeneous variability across regions. We assessed the overall sample size requirement and addressed the region-specific sample size determination to establish the consistency of treatment effects between the specific region and the entire group. We demonstrate the proposed approach with numerical examples.
引用
- Wu YJ, Cheng YC, Chiang C, et al. Use of likelihood estimates for variances for the design and evaluation of multiregional clinical trials with heterogeneous variances. Stat Med. 2021. PMID: 34705292. doi:10.1002/sim.9224
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。